Weekly Report: what happened at ARKG last week (0715-0719)?

ASCO Annual Meeting 2024: Breakthrough Treatments Hint At Renewed Hope For Patients And Investors

The 1-Minute Market Report July 12, 2024

Home Market Outlook Today's Market The 1-Minute Market Report. The S&P 500 notched its 37th record high on Wednesday of last week. The best-performing groups last week were the small caps. Investors rotated out of large caps and into small and mid-cap stocks.

Weekly Report: what happened at ARKG last week (0708-0712)?

Q3 2024 Equity Market Outlook

Home Market Outlook Today's Market Q3 2024 Equity Market Outlook: Neuberger Berman 2.93K Followers. We expect further corporate earnings growth across sectors, fueled by rising household net worth and a global industrial rebound. We recommend overweighting technology, communications and consumer discretionary stocks.

Cathie Wood Touts Palantir, Coinbase And Roku As ARK's Flagship Fund Shifts Focus From Mag 6 Amid 'Whiff' Of Lower Interest Rates

CEO of ARK Invest Cathie Wood highlighted the potential of the company's flagship fund, ARK Innovation ETF. She says the fund's performance has been impacted by the shift in focus from the "Magnificent Six" to multiomics stocks. ARKK's valuation has dropped to a level that is indicative of 'deep value territory'

Weekly Report: what happened at ARKG last week (0701-0705)?

CDT Insider Sentiment June 2024: Keep Your Seatbelt Fastened

Midyear Equity Outlook - Investing Beyond The Megacaps

Home Investing Strategy Portfolio Strategy Midyear Equity Outlook - Investing Beyond The Megacaps by Nelson Yu. The best performing sector has been technology with all of the AI powering the technology gains. Inflation has actually been more selective than the world expected. Lagging the stock market is consumer, not surprisingly.

Weekly Report: what happened at ARKG last week (0624-0628)?

ARK Genomic Revolution (ARKG) Enters Oversold Territory

Cathie Wood’s top and bottom performing ARKK holdings of H1

From AI To Green Metals: Strategic Investments For A Changing World

Green transition is driving this unprecedented demand for metals and minerals. By 2030, we will need 50 new lithium mines to meet the growing demand for electric vehicles (EVs) and renewable energy infrastructure. The clean appearance of EVs, solar panels, and windmills belies the dirty reality that they require lots and lots of mining.

Ginkgo Bioworks: Losing A Major Supporter

Cell programming and biosecurity company Ginkgo Bioworks faces bleak growth prospects. The company has slashed its revenue estimates for 2024 by $45 million. A major supporter of the company, Ark Invest, has started selling its shares. The stock has lost 80% of its value in the past year.

Cathie Wood’s Ark sells over 41M Ginkgo shares

Cathie Wood’s Ark sells over 41M Ginkgo shares Tuesday. The stock plunged to the lowest level since its public debut. About 62.9M shares of the cell programming platform company have changed hands so far. The selloff came after ARK ETFs sold 41.6M of shares of DNA on Monday.

Weekly Report: what happened at ARKG last week (0617-0621)?

ARKG: A Genomics Play But Active Isn't Adding Value

Weekly Report: what happened at ARKG last week (0610-0614)?

Weekly Report: what happened at ARKG last week (0603-0607)?

What The 2024 Elections Could Mean For Health Care Investors

Health care spending now accounts for 17% of the U.S. GDP. Election year volatility could mean opportunity for health care investors. The fate of medical exchanges and providers could be impacted by the election outcome. The outcome of the presidential election in 2024 could have implications for the health care sector.